Search research articles
Contact Us
Filters
Showing results (81-90 of 108) with videos related to
Page
of 11
Sort By:
The Prostate
|
September 23, 2015
Prognostic parameters for response to enzalutamide after docetaxel and abiraterone treatment in metastatic castration-resistant prostate cancer patients; a possible time relation
Sushil K Badrising, Vincent van der Noort, Alfons J M van den Eertwegh, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|
June 4, 2023
Blood platelet RNA profiles do not enable for nivolumab response prediction at baseline in patients with non-small cell lung cancer
Mirte Muller, Myron G Best, Vincent van der Noort, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 27, 2021
Technologic (R)Evolution Leads to Detection of More Sentinel Nodes in Patients with Melanoma in the Head and Neck Region
Danique M S Berger, Nynke S van den Berg, Vincent van der Noort, et al.
Prostate Cancer and Prostatic Diseases
|
August 27, 2021
Integrated analysis of pain, health-related quality of life, and analgesic use in patients with metastatic castration-resistant prostate cancer treated with Radium-223
Sushil K Badrising, Rebecca D Louhanepessy, Vincent van der Noort, et al.
BJC Reports
|
November 8, 2024
Long-term survival following anti-PD-(L)1 monotherapy in advanced urothelial cancer and an assessment of potential prognostic clinical factors: a multicentre observational study
Chantal F Stockem, Sarah M H Einerhand, Isabel Miras Rodríguez, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 26, 2026
Trametinib for NRAS-mutated tumors: Results from the Drug Rediscovery Protocol
Florentine A J Verbeek, Miguel P Martinez, Ilse A C Spiekman, et al.
The Lancet Regional Health. Europe
|
March 11, 2024
Cemiplimab in locally advanced or metastatic cutaneous squamous cell carcinoma: prospective real-world data from the DRUG Access Protocol
Karlijn Verkerk, Birgit S Geurts, Laurien J Zeverijn, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 12, 2024
Trastuzumab plus pertuzumab for HER2-amplified advanced colorectal cancer: Results from the drug rediscovery protocol (DRUP)
Ilse A C Spiekman, Laurien J Zeverijn, Birgit S Geurts, et al.
The Journal of Pathology
|
July 6, 2022
Feasibility of whole-genome sequencing-based tumor diagnostics in routine pathology practice
Kris G Samsom, Luuk J Schipper, Paul Roepman, et al.
Medrxiv : the Preprint Server for Health Sciences
|
March 3, 2023
Enhancer profiling identifies epigenetic markers of endocrine resistance and reveals therapeutic options for metastatic castration-resistant prostate cancer patients
Tesa M Severson, Yanyun Zhu, Stefan Prekovic, et al.
Page
of 11
Search research articles
Search
Showing results (81-90 of 108) with videos related to
Sort By:
Page
of 11
The Prostate
|
September 23, 2015
Prognostic parameters for response to enzalutamide after docetaxel and abiraterone treatment in metastatic castration-resistant prostate cancer patients; a possible time relation
Sushil K Badrising, Vincent van der Noort, Alfons J M van den Eertwegh, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|
June 4, 2023
Blood platelet RNA profiles do not enable for nivolumab response prediction at baseline in patients with non-small cell lung cancer
Mirte Muller, Myron G Best, Vincent van der Noort, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 27, 2021
Technologic (R)Evolution Leads to Detection of More Sentinel Nodes in Patients with Melanoma in the Head and Neck Region
Danique M S Berger, Nynke S van den Berg, Vincent van der Noort, et al.
Prostate Cancer and Prostatic Diseases
|
August 27, 2021
Integrated analysis of pain, health-related quality of life, and analgesic use in patients with metastatic castration-resistant prostate cancer treated with Radium-223
Sushil K Badrising, Rebecca D Louhanepessy, Vincent van der Noort, et al.
BJC Reports
|
November 8, 2024
Long-term survival following anti-PD-(L)1 monotherapy in advanced urothelial cancer and an assessment of potential prognostic clinical factors: a multicentre observational study
Chantal F Stockem, Sarah M H Einerhand, Isabel Miras Rodríguez, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 26, 2026
Trametinib for NRAS-mutated tumors: Results from the Drug Rediscovery Protocol
Florentine A J Verbeek, Miguel P Martinez, Ilse A C Spiekman, et al.
The Lancet Regional Health. Europe
|
March 11, 2024
Cemiplimab in locally advanced or metastatic cutaneous squamous cell carcinoma: prospective real-world data from the DRUG Access Protocol
Karlijn Verkerk, Birgit S Geurts, Laurien J Zeverijn, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 12, 2024
Trastuzumab plus pertuzumab for HER2-amplified advanced colorectal cancer: Results from the drug rediscovery protocol (DRUP)
Ilse A C Spiekman, Laurien J Zeverijn, Birgit S Geurts, et al.
The Journal of Pathology
|
July 6, 2022
Feasibility of whole-genome sequencing-based tumor diagnostics in routine pathology practice
Kris G Samsom, Luuk J Schipper, Paul Roepman, et al.
Medrxiv : the Preprint Server for Health Sciences
|
March 3, 2023
Enhancer profiling identifies epigenetic markers of endocrine resistance and reveals therapeutic options for metastatic castration-resistant prostate cancer patients
Tesa M Severson, Yanyun Zhu, Stefan Prekovic, et al.
Page
of 11